RT Journal Article T1 [Effectiveness of an intervention strategy in the biosimilar glargine prescription pattern in primary care]. T2 Efectividad de una estrategia de intervención en el patrón de prescripción del biosimilar glargina en atención primaria. A1 Saborido-Cansino, Carmen A1 Santos-Ramos, Bernardo A1 Carmona-Saucedo, Carmen A1 Rodríguez-Romero, María Victoria A1 González-Martín, Antonio A1 Palma-Amaro, Ana A1 Rojas-Lucena, Isabel María A1 Almeida-González, Carmen A1 Sánchez-Fidalgo, Susana K1 Atención primaria K1 Biosimilar K1 Glargina K1 Glargine K1 Intervención K1 Intervention K1 Primary care AB To examine the effects of specific interventions on biosimilar glargine insulin (BGI) prescribing in general practices and to analyse the influence of prescriber and economic impact. Non randomized controlled study. General practices in 2 health areas of Seville, intervention and control group. 220 general practices (intervention group) and 100 general practices (control group). Intervention group received educational seminars on biosimilar drugs, pharmacotherapeutic bulletin and prescribing feedback. The study was carried out from the biosimilar commercialization, October-2015, to February-2016 (pre-intervention) and from February to August 2016 (intervention). Percentage of patients and DDD with BGI respect to total glargine before and during intervention for both areas were analysed. Physicians have been analysed by subgroups of age, sex, training, type of contract, years of experience and quota. Both indicators for intervention group were significantly greater than for control group (P Intervention strategies aimed at training and information, as well as monitoring health professionals, influence the pattern of prescription and can have an economic impact. Our results have not been influenced by the profile of the prescriber. YR 2018 FD 2018-05-31 LK http://hdl.handle.net/10668/12539 UL http://hdl.handle.net/10668/12539 LA es DS RISalud RD Apr 12, 2025